Detalhe da pesquisa
1.
Association between adherence to posttreatment National Comprehensive Cancer Network (NCCN) surveillance guidelines and detection of recurrent uterine cancer.
Gynecol Oncol
; 181: 8-11, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38096674
2.
Patterns of care and outcomes of risk reducing surgery in women with pathogenic variants in non-BRCA and Lynch syndrome ovarian cancer susceptibility genes.
Gynecol Oncol
; 173: 1-7, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37030072
3.
Identification of Potent and Selective Acetylcholinesterase/Butyrylcholinesterase Inhibitors by Virtual Screening.
J Chem Inf Model
; 63(8): 2321-2330, 2023 04 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37011147
4.
Breast cancer surveillance following ovarian cancer in BRCA mutation carriers.
Gynecol Oncol
; 164(1): 202-207, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34862065
5.
Statin treatment is associated with survival in a nationally representative population of elderly women with epithelial ovarian cancer.
Gynecol Oncol
; 146(2): 340-345, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28596017
6.
Occult and subsequent cancer incidence following risk-reducing surgery in BRCA mutation carriers.
Gynecol Oncol
; 143(2): 231-235, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27623252
7.
Recurrence and risk of progression to lower genital tract malignancy in women with high grade VAIN.
Gynecol Oncol
; 141(3): 507-510, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27032375
8.
ADAM12 is a prognostic factor associated with an aggressive molecular subtype of high-grade serous ovarian carcinoma.
Carcinogenesis
; 36(7): 739-47, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25926422
9.
Impact of obesity on secondary cytoreductive surgery and overall survival in women with recurrent ovarian cancer.
Gynecol Oncol
; 138(2): 263-6, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26037901
10.
Too much, too late: Aggressive measures and the timing of end of life care discussions in women with gynecologic malignancies.
Gynecol Oncol
; 138(2): 383-7, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26049124
11.
Thrombocytosis at secondary cytoreduction for recurrent ovarian cancer predicts suboptimal resection and poor survival.
Gynecol Oncol
; 132(3): 556-9, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24423879
12.
Obesity-associated adipokines correlate with survival in epithelial ovarian cancer.
Gynecol Oncol
; 129(2): 353-7, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23402904
13.
Post treatment surveillance of type II endometrial cancer patients.
Gynecol Oncol
; 131(3): 609-12, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24051222
14.
Impact of beta blockers on epithelial ovarian cancer survival.
Gynecol Oncol
; 127(2): 375-8, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22819786
15.
Acetylcholinesterase Inhibition Assays for High-Throughput Screening.
Methods Mol Biol
; 2474: 47-58, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35294755
16.
DNA methylation and transcriptomic features are preserved throughout disease recurrence and chemoresistance in high grade serous ovarian cancers.
J Exp Clin Cancer Res
; 41(1): 232, 2022 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35883104
17.
CA125 surveillance increases optimal resectability at secondary cytoreductive surgery for recurrent epithelial ovarian cancer.
Gynecol Oncol
; 121(2): 249-52, 2011 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21300398
18.
Is older age a poor prognostic factor in stage I and II endometrioid endometrial adenocarcinoma?
Gynecol Oncol
; 120(2): 189-92, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21112078
19.
Identification of Compounds for Butyrylcholinesterase Inhibition.
SLAS Discov
; 26(10): 1355-1364, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34269114
20.
A direct peptide reactivity assay using a high-throughput mass spectrometry screening platform for detection of skin sensitizers.
Toxicol Lett
; 338: 67-77, 2021 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33290830